List of Tables
Table 1. Fast-acting Human Insulin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Fast-acting Human Insulin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Lispro Insulin
Table 4. Major Players of Aspart Insulin
Table 5. Major Players of Glulisine Insulin
Table 6. Global Fast-acting Human Insulin Sales by Type (2018-2023) & (K Units)
Table 7. Global Fast-acting Human Insulin Sales Market Share by Type (2018-2023)
Table 8. Global Fast-acting Human Insulin Revenue by Type (2018-2023) & ($ million)
Table 9. Global Fast-acting Human Insulin Revenue Market Share by Type (2018-2023)
Table 10. Global Fast-acting Human Insulin Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Fast-acting Human Insulin Sales by Application (2018-2023) & (K Units)
Table 12. Global Fast-acting Human Insulin Sales Market Share by Application (2018-2023)
Table 13. Global Fast-acting Human Insulin Revenue by Application (2018-2023)
Table 14. Global Fast-acting Human Insulin Revenue Market Share by Application (2018-2023)
Table 15. Global Fast-acting Human Insulin Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Fast-acting Human Insulin Sales by Company (2018-2023) & (K Units)
Table 17. Global Fast-acting Human Insulin Sales Market Share by Company (2018-2023)
Table 18. Global Fast-acting Human Insulin Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Fast-acting Human Insulin Revenue Market Share by Company (2018-2023)
Table 20. Global Fast-acting Human Insulin Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Fast-acting Human Insulin Producing Area Distribution and Sales Area
Table 22. Players Fast-acting Human Insulin Products Offered
Table 23. Fast-acting Human Insulin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Fast-acting Human Insulin Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Fast-acting Human Insulin Sales Market Share Geographic Region (2018-2023)
Table 28. Global Fast-acting Human Insulin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Fast-acting Human Insulin Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Fast-acting Human Insulin Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Fast-acting Human Insulin Sales Market Share by Country/Region (2018-2023)
Table 32. Global Fast-acting Human Insulin Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Fast-acting Human Insulin Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Fast-acting Human Insulin Sales by Country (2018-2023) & (K Units)
Table 35. Americas Fast-acting Human Insulin Sales Market Share by Country (2018-2023)
Table 36. Americas Fast-acting Human Insulin Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Fast-acting Human Insulin Revenue Market Share by Country (2018-2023)
Table 38. Americas Fast-acting Human Insulin Sales by Type (2018-2023) & (K Units)
Table 39. Americas Fast-acting Human Insulin Sales by Application (2018-2023) & (K Units)
Table 40. APAC Fast-acting Human Insulin Sales by Region (2018-2023) & (K Units)
Table 41. APAC Fast-acting Human Insulin Sales Market Share by Region (2018-2023)
Table 42. APAC Fast-acting Human Insulin Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Fast-acting Human Insulin Revenue Market Share by Region (2018-2023)
Table 44. APAC Fast-acting Human Insulin Sales by Type (2018-2023) & (K Units)
Table 45. APAC Fast-acting Human Insulin Sales by Application (2018-2023) & (K Units)
Table 46. Europe Fast-acting Human Insulin Sales by Country (2018-2023) & (K Units)
Table 47. Europe Fast-acting Human Insulin Sales Market Share by Country (2018-2023)
Table 48. Europe Fast-acting Human Insulin Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Fast-acting Human Insulin Revenue Market Share by Country (2018-2023)
Table 50. Europe Fast-acting Human Insulin Sales by Type (2018-2023) & (K Units)
Table 51. Europe Fast-acting Human Insulin Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Fast-acting Human Insulin Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Fast-acting Human Insulin Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Fast-acting Human Insulin Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Fast-acting Human Insulin Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Fast-acting Human Insulin Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Fast-acting Human Insulin Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Fast-acting Human Insulin
Table 59. Key Market Challenges & Risks of Fast-acting Human Insulin
Table 60. Key Industry Trends of Fast-acting Human Insulin
Table 61. Fast-acting Human Insulin Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Fast-acting Human Insulin Distributors List
Table 64. Fast-acting Human Insulin Customer List
Table 65. Global Fast-acting Human Insulin Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Fast-acting Human Insulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Fast-acting Human Insulin Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Fast-acting Human Insulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Fast-acting Human Insulin Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Fast-acting Human Insulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Fast-acting Human Insulin Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Fast-acting Human Insulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Fast-acting Human Insulin Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Fast-acting Human Insulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Fast-acting Human Insulin Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Fast-acting Human Insulin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Fast-acting Human Insulin Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Fast-acting Human Insulin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Sanofi Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Fast-acting Human Insulin Product Portfolios and Specifications
Table 81. Sanofi Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. Geropharm Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 85. Geropharm Fast-acting Human Insulin Product Portfolios and Specifications
Table 86. Geropharm Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Geropharm Main Business
Table 88. Geropharm Latest Developments
Table 89. Wockhardt Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 90. Wockhardt Fast-acting Human Insulin Product Portfolios and Specifications
Table 91. Wockhardt Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Wockhardt Main Business
Table 93. Wockhardt Latest Developments
Table 94. Novo Nordisk Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 95. Novo Nordisk Fast-acting Human Insulin Product Portfolios and Specifications
Table 96. Novo Nordisk Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Novo Nordisk Main Business
Table 98. Novo Nordisk Latest Developments
Table 99. Eli Lilly and Company Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 100. Eli Lilly and Company Fast-acting Human Insulin Product Portfolios and Specifications
Table 101. Eli Lilly and Company Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Eli Lilly and Company Main Business
Table 103. Eli Lilly and Company Latest Developments
Table 104. Mannkind Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 105. Mannkind Fast-acting Human Insulin Product Portfolios and Specifications
Table 106. Mannkind Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Mannkind Main Business
Table 108. Mannkind Latest Developments
Table 109. Biocon Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 110. Biocon Fast-acting Human Insulin Product Portfolios and Specifications
Table 111. Biocon Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Biocon Main Business
Table 113. Biocon Latest Developments
Table 114. Julphar Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 115. Julphar Fast-acting Human Insulin Product Portfolios and Specifications
Table 116. Julphar Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Julphar Main Business
Table 118. Julphar Latest Developments
Table 119. ADOCIA Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 120. ADOCIA Fast-acting Human Insulin Product Portfolios and Specifications
Table 121. ADOCIA Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. ADOCIA Main Business
Table 123. ADOCIA Latest Developments
Table 124. Tonghua Dongbao Pharmaceutical Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 125. Tonghua Dongbao Pharmaceutical Fast-acting Human Insulin Product Portfolios and Specifications
Table 126. Tonghua Dongbao Pharmaceutical Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Tonghua Dongbao Pharmaceutical Main Business
Table 128. Tonghua Dongbao Pharmaceutical Latest Developments
Table 129. Gan & Lee Pharmaceuticals Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 130. Gan & Lee Pharmaceuticals Fast-acting Human Insulin Product Portfolios and Specifications
Table 131. Gan & Lee Pharmaceuticals Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Gan & Lee Pharmaceuticals Main Business
Table 133. Gan & Lee Pharmaceuticals Latest Developments
Table 134. Zhejiang Hisun Pharmaceutical Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 135. Zhejiang Hisun Pharmaceutical Fast-acting Human Insulin Product Portfolios and Specifications
Table 136. Zhejiang Hisun Pharmaceutical Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Zhejiang Hisun Pharmaceutical Main Business
Table 138. Zhejiang Hisun Pharmaceutical Latest Developments
Table 139. Wuhan Biology Chemical Pharmacy Basic Information, Fast-acting Human Insulin Manufacturing Base, Sales Area and Its Competitors
Table 140. Wuhan Biology Chemical Pharmacy Fast-acting Human Insulin Product Portfolios and Specifications
Table 141. Wuhan Biology Chemical Pharmacy Fast-acting Human Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Wuhan Biology Chemical Pharmacy Main Business
Table 143. Wuhan Biology Chemical Pharmacy Latest Developments
LIST OF FIGURE
List of Figures
Figure 1. Picture of Fast-acting Human Insulin
Figure 2. Fast-acting Human Insulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fast-acting Human Insulin Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Fast-acting Human Insulin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Fast-acting Human Insulin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Lispro Insulin
Figure 10. Product Picture of Aspart Insulin
Figure 11. Product Picture of Glulisine Insulin
Figure 12. Global Fast-acting Human Insulin Sales Market Share by Type in 2022
Figure 13. Global Fast-acting Human Insulin Revenue Market Share by Type (2018-2023)
Figure 14. Fast-acting Human Insulin Consumed in Type 1 Diabetes
Figure 15. Global Fast-acting Human Insulin Market: Type 1 Diabetes (2018-2023) & (K Units)
Figure 16. Fast-acting Human Insulin Consumed in Type 2 Diabetes
Figure 17. Global Fast-acting Human Insulin Market: Type 2 Diabetes (2018-2023) & (K Units)
Figure 18. Global Fast-acting Human Insulin Sales Market Share by Application (2022)
Figure 19. Global Fast-acting Human Insulin Revenue Market Share by Application in 2022
Figure 20. Fast-acting Human Insulin Sales Market by Company in 2022 (K Units)
Figure 21. Global Fast-acting Human Insulin Sales Market Share by Company in 2022
Figure 22. Fast-acting Human Insulin Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Fast-acting Human Insulin Revenue Market Share by Company in 2022
Figure 24. Global Fast-acting Human Insulin Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Fast-acting Human Insulin Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Fast-acting Human Insulin Sales 2018-2023 (K Units)
Figure 27. Americas Fast-acting Human Insulin Revenue 2018-2023 ($ Millions)
Figure 28. APAC Fast-acting Human Insulin Sales 2018-2023 (K Units)
Figure 29. APAC Fast-acting Human Insulin Revenue 2018-2023 ($ Millions)
Figure 30. Europe Fast-acting Human Insulin Sales 2018-2023 (K Units)
Figure 31. Europe Fast-acting Human Insulin Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Fast-acting Human Insulin Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Fast-acting Human Insulin Revenue 2018-2023 ($ Millions)
Figure 34. Americas Fast-acting Human Insulin Sales Market Share by Country in 2022
Figure 35. Americas Fast-acting Human Insulin Revenue Market Share by Country in 2022
Figure 36. Americas Fast-acting Human Insulin Sales Market Share by Type (2018-2023)
Figure 37. Americas Fast-acting Human Insulin Sales Market Share by Application (2018-2023)
Figure 38. United States Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Fast-acting Human Insulin Sales Market Share by Region in 2022
Figure 43. APAC Fast-acting Human Insulin Revenue Market Share by Regions in 2022
Figure 44. APAC Fast-acting Human Insulin Sales Market Share by Type (2018-2023)
Figure 45. APAC Fast-acting Human Insulin Sales Market Share by Application (2018-2023)
Figure 46. China Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Fast-acting Human Insulin Sales Market Share by Country in 2022
Figure 54. Europe Fast-acting Human Insulin Revenue Market Share by Country in 2022
Figure 55. Europe Fast-acting Human Insulin Sales Market Share by Type (2018-2023)
Figure 56. Europe Fast-acting Human Insulin Sales Market Share by Application (2018-2023)
Figure 57. Germany Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Fast-acting Human Insulin Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Fast-acting Human Insulin Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Fast-acting Human Insulin Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Fast-acting Human Insulin Sales Market Share by Application (2018-2023)
Figure 66. Egypt Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Fast-acting Human Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Fast-acting Human Insulin in 2022
Figure 72. Manufacturing Process Analysis of Fast-acting Human Insulin
Figure 73. Industry Chain Structure of Fast-acting Human Insulin
Figure 74. Channels of Distribution
Figure 75. Global Fast-acting Human Insulin Sales Market Forecast by Region (2024-2029)
Figure 76. Global Fast-acting Human Insulin Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Fast-acting Human Insulin Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Fast-acting Human Insulin Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Fast-acting Human Insulin Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Fast-acting Human Insulin Revenue Market Share Forecast by Application (2024-2029)
